MZL
Showing 126 - 137 of 137
Indolent Non-Hodgkin's Lymphomas Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)
Terminated
- Indolent Non-Hodgkin's Lymphomas
- Idelalisib
- +3 more
-
Huntsville, Alabama
- +143 more
Oct 19, 2018
CD180 Overexpression in Follicular Lymphoma
Completed
- Follicular Lymphoma
- (no location specified)
Nov 29, 2016
Non Hodgkin Lymphoma (NHL) Trial in Praha
Recruiting
- Non Hodgkin Lymphoma (NHL)
-
Praha, CzechiaCharles University General Hospital
Jun 21, 2017
B-Cell Chronic Lymphocytic Leukemia Trial in Canada, Russian Federation, Spain (Ibrutinib, Erythromycin, Voriconazole)
Completed
- B-Cell Chronic Lymphocytic Leukemia
- Ibrutinib
- +2 more
-
N/a N/a, Canada
- +5 more
Jun 23, 2017
Marginal Zone Lymphoma Trial in Miami (Rituximab, Ibritumomab Tiuxetan)
Completed
- Marginal Zone Lymphoma
- Rituximab
- Ibritumomab Tiuxetan
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center - Miam
Nov 30, 2015
Lymphoma, Non-Hodgkin, MALT Lymphoma Trial in Boston, Rochester (Fludarabine, Rituximab)
Completed
- Lymphoma, Non-Hodgkin
- MALT Lymphoma
-
Boston, Massachusetts
- +3 more
Jul 28, 2016
B-cell Lymphomas Trial in Busan (Oxaliplatin, Prednisolone)
Completed
- B-cell Lymphomas
- Oxaliplatin, Prednisolone
-
Busan, Korea, Republic ofDong-A University Hospital
Nov 2, 2014
Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial in Melbourne (Eltrombopag and Vorinostat)
Terminated
- Follicular Lymphoma
- +2 more
- Eltrombopag and Vorinostat
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Feb 12, 2016
Relapsed or Refractory Marginal Zone B-cell Lymphoma Trial in Seoul (131I-rituximab)
Unknown status
- Relapsed or Refractory Marginal Zone B-cell Lymphoma
-
Seoul, Korea, Republic ofKorea Cancer Center Hospital, Korea Institute of Radiological an
Sep 4, 2012